Here is a good post by
@gingerclam today. Worth noting the speaker Hassan De Silva is probably one of the best Biotech analysts out there.
https://hotcopper.com.au/posts/74761760/singleWhat appeals to me, is our Fast Track designation for treating Bile Duct Cancer! It’s started dosing last week. With only 10 pax needed , and probably at OBD, we might have our very first FDA marketing approval in view.
Considering the amount of BEAUTIFUL DATA IMU has collected particularly in the gastric space , this 10 Pax trial might just get us our first approval.
This is a rare disease. An orphan disease .
If this works out IMU will be off to the races here. And will know that by years end.
It’s quite possible just the release of the Bile Duct Trial results might set this off. Of course the release of specific news about further expansion trials will addd add fuel to this fire! Let’s hope we get an announcement that says “FDA approves expansion trial for ####### cancer”
